ISPOR Award for Excellence in Application of Pharmacoeconomics and Health Outcomes Research

John Hsu, MD, MBA, MSCE
Physician Scientist
Kaiser Division of Research
Kaiser Institute for Health Policy

Hsu J, Price M, Huang J, et al. Unintended Consequences of Caps on Medicare Drug Benefits. N Engl J Med 2006;354:2349-59.

John Hsu, MD, MBA, MSCE, is a Physician Scientist at the Kaiser Division of Research, Fellow at the Kaiser Institute for Health Policy, and Faculty at the University of California, San Francisco, Institute for Health Policy Studies and the Department of Epidemiology and Biostatistics. He received his MD and MSCE from the University of Pennsylvania School of Medicine, and his MBA from the Wharton School of Business.

Dr. Hsu studies changes in the financing and delivery of health care at the system level, with particular focus on the clinical and economic implications of these changes. He has ongoing NIH- and AHRQ-sponsored studies on the effects of patient cost-sharing for prescription drugs and medical care, and the impact of health information technology on prescribing for patients with chronic conditions. He has published extensively in journals including the New England Journal of Medicine, British Medical Journal, Health Services Research, and Medical Care.